Moleculin Biotech (NASDAQ:MBRX) will host a conference call
on April 16, at 4:30 pm ET to explain the significance of recent
discovery that the active compound in WP1122 has been shown to reduce
replication of SARS-CoV-2 by 100%.
https://seekingalpha.com/news/3560422-moleculin-biotech-to-hold-investor-call-on-april-16-shares-up-12-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.